TEVA

On August 4, 2023, I bought additional 2 shares of Teva Pharmaceutical Industries Ltd (NYSE: TEVA) stock, paying $9.98 per share for our long-term dividend stock portfolio Teva Pharmaceutical Industries Ltd. is an Israeli multinational pharmaceutical company with headquarters in Tel Aviv, Israel. It specializes primarily in generic drugs, but other business interests include active pharmaceutical ingredients and, to a lesser extent, proprietary pharmaceuticals. We are now holding 4 shares of…